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Glasgow and Clydebank, United Kingdom; and Brisbane, AustraliaOBJECTIVES This study aimed to compare dobutamine stress cardiac magnetic resonance (DSCMR)
with dobutamine stress echocardiography (DSE) in patients with left bundle branch block (LBBB) and
suspected coronary artery disease (CAD).
BACKGROUND Noninvasive diagnosis of CAD in patients with pre-existent LBBB is difﬁcult because
single-photon emission computed tomography and stress echocardiography both have limitations. We
hypothesized that a comprehensive DSCMR examination including cine, perfusion, and late gadolinium
enhancement imaging would be more accurate than DSE, thus potentially reducing the number of un-
necessary invasive coronary angiograms.
METHODS We prospectively evaluated 82 consecutive patients with LBBB referred to our cardiology
clinic for investigation of suspected CAD. All 82 patients underwent DSE, DSCMR, and invasive quan-
titative coronary angiography within 14 days. We compared the diagnostic accuracy of DSE, CMR cine
imaging, the additive value of ﬁrst-pass perfusion, and late gadolinium enhancement. In the comprehen-
sive examination, a positive result was adjudged as the presence of either subendocardial or transmural
late gadolinium enhancement with or without inducible peri-infarct ischemia or an inducible perfusion
defect corresponding to an inducible regional wall motion abnormality.
RESULTS CMR cine imaging (regional wall motion abnormalities) had higher speciﬁcity, negative pre-
dictive value, and overall diagnostic accuracy than did DSE (87.5% vs. 72.9%; 80.8% vs. 67.3%; and 80.4% vs.
72.0%, respectively), although sensitivity was the same (72.0%). The addition of ﬁrst-pass stress perfusion
and late gadolinium enhancement (scar) further improved diagnostic conﬁdence (sensitivity 82.4%, speciﬁcity
95.8%, positive predictive value 93.3%, negative predictive value 88.5%, and diagnostic accuracy 90.2%).
CONCLUSIONS DSCMR is a safe procedure and has greater diagnostic accuracy than does DSE in
assessing patients with suspected CAD and LBBB. A comprehensive examination with the addition of
perfusion and late gadolinium enhancement to CMR cine imaging signiﬁcantly boosted speciﬁcity and
sensitivity, making DSCMR a reliable alternative to invasive quantitative coronary angiography in this
group of patients. (J Am Coll Cardiol Img 2014;7:490–8) ª 2014 by the American College of Cardiology
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491eft bundle branch block (LBBB) is a cardiac
conduction abnormality that causes the left
side of the heart to contract later than
the right side does (1). The prevalence of
LBBB increases with age, and coronary artery dis-
ease (CAD) is the most common cause, with a
prevalence estimated at 30% to 52% (2,3). Perhaps
because of this, patients with LBBB have been
shown to have signiﬁcantly increased cardio-
vascular mortality (4).See page 499
A B B R E V I A T I O N S
A N D A C R O N YM S
AUC = area under the curve
CAD = coronary artery disease
CMR = cardiac magnetic
resonance
DSCMR = dobutamine stress
cardiac magnetic resonance
DSE = dobutamine stress
echocardiography
ECG = electrocardiography
ICA = invasive coronary
angiography
LBBB = left bundle branch block
LGE = late gadolinium
enhancement
RWMA = regional wall motion
abnormality
SPECT = single-photon emission
computed tomographyGiven this situation, initial investigation of inci-
dental LBBB is often directed toward exclusion of
CAD. The majority of these patients have inter-
mediate probability for CAD, and most pathways
for investigation of CAD in the intermediate pro-
bability group recommend noninvasive functional
assessment such as exercise electrocardiography
(ECG), single-photon emission computed tomog-
raphy (SPECT), or stress echocardiography (5,6).
Whereas these techniques are robust and well
validated in the general population, in patients
with LBBB, they have certain limitations (7–11).
Cardiac magnetic resonance (CMR) has the ability
to overcome some of the disadvantages of other
noninvasive investigations; however, its utility and
potential superiority in this setting has not yet been
established.
We hypothesized that, in patients with LBBB
and suspected CAD, a comprehensive dobutamine
stress cardiac magnetic resonance (DSCMR) ex-
amination including wall motion analysis, perfusion,
and late gadolinium enhancement (LGE) imaging
would be more accurate in diagnosis of CAD than
dobutamine stress echocardiography (DSE) would
be when compared to the gold standard of invasive
coronary angiography (ICA).
METHODS
Study population. We prospectively investigated 82
consecutive patients with LBBB who were referred
to our clinic with suspected CAD over a period of
12 months. All patients underwent DSE, DSCMR,
and ICA. All tests were performed within 14  8
days by observers blinded to results of the others.
The study protocol is summarized in Figure 1.
We included patients with LBBB and suspected
CAD based on clinical judgment of the referring
cardiologist. Patients were of intermediate proba-
bility of CAD as recommended by current clinical
guidelines for investigation of suspected stableangina (5,11–13). The patients were all age $40
years and had typical features of angina (exertional
chest pain or dyspnea) with 1 or more risk factors.
We excluded patients who had a previous history of
established CAD, those with renal impairment
(estimated glomerular ﬁltration rate <60 ml/min/
1.73 m2), metallic implants incompatible with CMR,
uncontrolled arterial hypertension (baseline systolic
blood pressure >190 mm Hg or diastolic blood
pressure >100 mm Hg), atrial ﬁbrillation with un-
controlled ventricular response, and prior adverse
reaction to dobutamine. Antianginal medications,
including oral beta-blockers, calcium-channel blockers,
and nitrates, were not discontinued before DSCMR.
For each examination (DSCMR, DSE, and ICA),
analysis was performed by 2 observers blinded to
the results of the other investigations. In
case of any doubt, a third independent
observer was used to adjudicate. All patients
provided written informed consent to un-
dergo DSCMR, DSE, and ICA, and the
local ethics committee approved the study.
Dobutamine stress echocardiography.
Two-dimensional transthoracic DSE was
carried out in all patients using an
IE33 scanner (Philips, Amsterdam, the
Netherlands). All patients were pharma-
cologically stressed using dobutamine
starting at a rate of 10 mg/kg/min and
increased at 3-min intervals to 20, 30, and
40 mg/kg/min. If the target heart rate was
not reached with dobutamine, intravenous
boluses of atropine sulfate (0.25 to 0.5 mg
aliquots up to a maximum total dose of
2 mg) were used at 30 or 40 mg/kg/min
stages to augment the heart rate response.
All studies were carried out with the pa-
tient in the left lateral position and with continu-
ous ECG monitoring. Standard echocardiographic
views were taken (parasternal long- and short-axis;
apical 2-, 3-, 4-, and 5-chamber; and subcostal
views). Images were acquired at rest and peak stress.
Indications for terminating the dobutamine infu-
sion were the following: the patient reaching target
heart rate (i.e., 85% of predicted for age); occur-
rence of a new wall motion abnormality; develop-
ment of signiﬁcant symptoms (e.g., chest pain,
dyspnea); or signiﬁcant ECG changes such as ar-
rhythmias. Intravenous contrast was used for all
patients at both rest and stress.
Comprehensive DSCMR. DSCMR was performed
with a 1.5-T system (Avanto Magnetom, Siemens,
Erlangen, Germany). The order of sequences is sum-
marized in Figure 2, and detailed CMR methods
Figure 1. Summary of the Study Protocol
In our study, 82 patients underwent dobutamine stress echocardiography
or dobutamine stress cardiac magnetic resonance (CMR) before undergoing
invasive coronary angiography. CAD ¼ coronary artery disease.
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492and analysis are provided in the supplementary
methods in the Online Appendix. Dobutamine was
infused at progressive 3-min stages of 10, 20, 30, and
40 mg/kg/min. Intravenous boluses of atropine sul-
fate (0.25 to 0.5 mg aliquots up to a maximum total
dose of 2 mg) were used at the 30 or 40 mg/kg/min
stages to augment the heart rate response. At the
stage of 20 mg/kg/min dobutamine stress (henceforth
deﬁned as intermediate dose), intravenous gadolinium-
tetraazacyclododecanetetraacetic acid (0.1 mmol/kg)
was injected and ﬁrst-pass myocardial perfusion
images were acquired. This dose was selected due
to our previous clinical experience suggesting that
at higher doses of dobutamine, the increase in
contractility and heart rate makes it difﬁcult to
qualitatively interpret the ﬁrst-pass perfusion im-
ages. Furthermore, there is also some evidence that
myocardial perfusion can be accurately assessed at
20 mg/kg/min with a similar increase in myocardial
blood ﬂow to adenosine at this dose (14–16). LGE
imaging for myocardial infarction was acquired 10
min after intravenous contrast administration by an
inversion recovery fast gradient-echo sequence as
previously reported (17). Infarcted myocardium was
quantitated by semiautomatic detection of any re-
gion with signal intensity 2 SD above the mean
signal intensity of the remote myocardium as pre-
viously validated (17). LGE was counted as positive
only if it was in a subendocardial or transmural
distribution typical of CAD.Using CMR cine imaging alone, CMR was
judged to be positive if an inducible regional wall
motion abnormality (RWMA) was seen. In the
comprehensive DSCMR examination, the test was
adjudged to be positive: 1) if there was LGE pre-
sent in a distribution typical of infarction (sub-
endocardial or transmural) with or without evidence
of peri-infarct ischemia; or 2) if there was no LGE,
if there was an inducible perfusion defect that cor-
responded to an inducible RWMA.
Invasive coronary angiography. ICA was performed
in all 82 patients. An experienced investigator
blinded to echocardiographic and CMR ﬁnd-
ings assessed the presence of coronary stenoses in
2 orthogonal views of each BARI (Bypass Angio-
plasty Revascularization Investigation)-deﬁned seg-
ment by quantitative coronary angiography analysis
using GE automated edge detection software, which
calibrates using the coronary guide catheter as its
reference diameter (Centricity Cardiology CA1000,
GE Healthcare, Dornstadt, Germany). Signiﬁcant
stenoses were deﬁned as $70% luminal narrowing
in the most severe view ($50% for left main ste-
nosis). Patients were classiﬁed as having 1-, 2-, and
3-vessel disease.
Statistical analysis. All continuous variables were
expressed as mean  SD. A 2-tailed p value <0.05
was considered signiﬁcant. Categorical data are pre-
sented as absolute values with percentage in paren-
theses and were compared by chi-square or Fisher
exact test as appropriate. Sensitivities, speciﬁcities,
positive and negative predictive values, chi-square
statistics and the area under the curve (AUC) of
stress echocardiography, CMR wall motion ana-
lysis, and a comprehensive CMR examination for
detection of >70% coronary stenoses by quantita-
tive coronary angiography analysis were calculated.
Comparisons between diagnostic techniques were
made with the McNemar test. The AUC between
the tests was calculated using the method of
DeLong et al. (18). All statistics were analyzed
using SPSS software (version 19.0, IBM Corpo-
ration, Armonk, New York), except for the com-
parison between the AUC, which was conducted
using MedCalc software (version 12.7.0, MedCalc,
Ostend, Belgium).
RESULTS
Baseline characteristics. All 82 patients complet-
ed the investigations successfully without any
complications. There were no patients with sub-
optimal imaging as judged by the independent
observers. There were no major adverse events.
Figure 2. Summary of the CMR Protocol
Protocol for comprehensive dobutamine stress cardiac magnetic resonance (CMR) in which all patients underwent cine imaging at rest and
stress, ﬁrst-pass perfusion at intermediate dose, and late gadolinium enhancement (LGE) imaging.
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493The mean peak dose of dobutamine given was
35.4  5.7 mg/kg/min and mean peak heart rate
was 143.3  10.0 beats/min. Patient characteristics
are summarized in Table 1 and hemodynamic pa-
rameters are summarized in Table 2.
The mean age of patients with CAD was 57.1 
8.9 years, compared with 55.9  6.6 years for patients
without CAD. The cohort was typical of a group
with intermediate pre-test probability for CAD,Table 1. Baseline Characteristics
All Patients
(n [ 82)
Age, yrs 56.5  7.8
Male 53 (64.6)
QRS duration, ms 133.0  8.1
Hypertension 38 (46.3)
Diabetes mellitus 19 (23.2)
Peripheral arterial disease 17 (20.7)
COPD 12 (14.6)
Hyperlipidemia 39 (47.6)
Smoker 33 (40.2)
Alcohol excess 9 (11.0)
Family history of CAD 37 (45.1)
Aspirin 22 (26.8)
Beta-blocker 13 (15.9)
Oral nitrate 4 (4.9)
Statin 32 (39.0)
Calcium-channel antagonist 25 (30.5)
ACE inhibitor 31 (37.8)
Values are mean  SD or n (%). Bold p value is statistically signiﬁcant.
ACE ¼ angiotensin-converting enzyme; CAD ¼ coronary artery disease; COPD ¼with the most common conditions encountered in
our patient population being hypercholesterolemia,
smoking, hypertension, and family history of CAD.
The only signiﬁcant difference between those with
CAD and those without was the presence of hy-
pertension (61.8% in patients with CAD vs. 35.4%
in patients without CAD; p ¼ 0.018).
DSE and DSCMR compared with ICA. Following
quantitative analysis of ICA, 34 patients wereCAD
(n [ 34)
No CAD
(n [ 48) p Value
57.2  9.2 56.0  6.6 0.50
23 (67.6) 30 (62.5) 0.63
134.5  7.0 132.2  8.7 0.19
21 (61.8) 17 (35.4) 0.018
11 (32.4) 8 (16.7) 0.10
7 (20.6) 10 (20.8) 0.98
6 (17.6) 6 (12.5) 0.54
14 (41.2) 25 (52.1) 0.33
12 (35.3) 21 (43.8) 0.44
3 (8.8) 6 (12.5) 0.73
13 (38.2) 24 (50.0) 0.29
9 (26.5) 13 (37.1) 0.34
6 (17.6) 7 (14.6) 0.71
0 (0.0) 4 (8.3) 0.14
13 (38.2) 19 (39.6) 0.90
14 (41.2) 11 (22.9) 0.08
16 (47.1) 15 (31.3) 0.15
chronic obstructive pulmonary (airways) disease.
Table 2. Hemodynamic Data for DSCMR
Resting heart rate, beats/min 71  9
Maximal heart rate, beats/min 143.3  10.0
Resting systolic BP, mm Hg 132  20
Peak systolic BP, mm Hg 162  10
Resting diastolic BP, mm Hg 72  9
Peak diastolic BP 71  11
Peak dose of dobutamine, mg 35.4  5.71
Number reaching target HR, 85% of predicted 82 (100.0)
Atropine given 79 (96.3)
Values are mean  SD or n (%).
BP ¼ blood pressure; DSCMR ¼ dobutamine stress cardiac magnetic reso-
nance; HR ¼ heart rate.
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494deemed to have signiﬁcant CAD. For assessment of
inducible wall motion abnormalities, DSCMR and
DSE had the same sensitivity (70.6%); however,
cine imaging had improved speciﬁcity (87.5% vs.
72.9%), leading to a higher diagnostic accuracy
(80.4% vs. 72.0%). Positive and negative predictive
values for wall motion interpretation by CMR were
80.0% and 80.8%, respectively; whereas for echo-
cardiography, values were 64.9% and 77.8%
(Table 3). Examples of typical ﬁndings using
DSCMR are shown in Figures 3 to 5.
There was an incremental beneﬁt in diagnostic
accuracy with the addition of stress perfusion imag-
ing and LGE as outlined in Table 3. Eleven patients
had LGE; in all patients, this was in an ischemic
pattern (subendocardial or transmural). No patients
had a subepicardial or midwall pattern of LGE sug-
gestive of an underlying cardiomyopathy. Sensitivity
was 82.4%, whereas speciﬁcity increased to 95.8%,
giving an improved overall diagnostic accuracy of
90.2%. Using the receiver-operating characteristic,
the AUC is greatest for a comprehensive DSCMR
examination and is signiﬁcantly better than DSE
(AUC: 0.89 vs. 0.72, respectively; p < 0.05).
Of the 34 patients with CAD identiﬁed by in-
vasive angiography, 14 had left anterior descendingTable 3. Per-Patient Diagnostic Performance of DSE and CMR
Sensitivity Speciﬁcity
DSE 70.6 (24/34) 72.9 (35/48)
CMR cine imaging only 70.6 (24/34) 87.5 (42/48)
First-pass perfusion 70.6 (24/34) 93.8 (45/48)
LGE 41.5 (11/34) 100.0 (48/48)
Comprehensive DSCMR 82.4 (28/34) 95.8 (46/48)
Values are % (n/N). *p < 0.05 between comprehensive CMR and DSE.
AUC ¼ area under the curve; CMR ¼ cardiac magnetic resonance; DSCMR ¼ dob
echocardiography; LGE ¼ late gadolinium enhancement; NPV ¼ negative predictivdisease, 14 left circumﬂex disease, 5 right coronary
artery disease, and 1 had 2-vessel disease. Table 4
summarizes the respective performance of each
noninvasive technique in comparison to invasive
angiography for determining the affected coronary
artery territory. In the left coronary circulation,
comprehensive DSCMR had improved sensitivity
in comparison to DSE and CMR cine imaging (left
anterior descending: 71.4% vs. 64.3% vs. 57.1%; left
circumﬂex: 92.9% vs. 64.3% vs. 78.6%, respectively).
Sensitivity for the left-sided circulation was DSE
64.2%, CMR cine imaging 67.9%, and compre-
hensive DSCMR 82.1%. Both CMR techniques
failed to identify 1 RCA lesion that was correctly
identiﬁed by DSE. All 3 techniques correctly iden-
tiﬁed the presence of 2-vessel disease in 1 patient.DISCUSS ION
Our study is the ﬁrst prospective evaluation using a
comprehensive DSCMR examination of patients
with LBBB for the diagnosis of CAD. Regard-
ing our primary hypothesis, we have shown that
DSCMR is a safe procedure that has a higher
diagnostic accuracy than DSE does. Additionally,
we have shown that there is an incremental beneﬁt
in diagnostic accuracy in using a comprehensive
examination including CMR cine imaging, ﬁrst-
pass stress perfusion, and LGE over using CMR
cine imaging alone.
The prevalence of LBBB increases with age (up
to around 17% at the age of 80 years in a Northern
European population), and it is known to confer an
adverse prognosis, at least in part due to the risk of
cardiac death (2–4). The prevalence of CAD in
patients with LBBB is thought to be between 30%
and 50%; therefore, given the poor prognosis of
LBBB, it would be beneﬁcial to identify those who
may beneﬁt from revascularization (19).
Presently, however, diagnosis of CAD in patients
with LBBB is difﬁcult. Functional noninvasive testsAccuracy PPV NPV AUC
72.0 (59/82) 64.9 (24/37) 77.8 (35/45) 0.72
80.4 (66/82) 80.0 (24/30) 80.8 (42/52) 0.79
84.1 (69/82) 88.9 (24/27) 81.8 (45/55) 0.82
72.0 (59/82) 100.0 (11/11) 67.6 (48/71) 0.66
90.2 (74/82) 93.3 (28/30) 88.5 (46/52) 0.89*
utamine stress cardiac magnetic resonance imaging; DSE ¼ dobutamine stress
e value; PPV ¼ positive predictive value.
Figure 3. An Example of a Correct Diagnosis of CAD by CMR Cine Imaging, Perfusion, and LGE
A patient with a resting inferior wall motion abnormality (A and B, arrows). There is a subtle inducible perfusion defect at stress but not rest
(C and D, arrow). There is subendocardial LGE in the same region; however, the perfusion defect is larger, suggesting peri-infarct ischemia
(E, arrow). The comprehensive dobutamine stress CMR is suggestive of CAD affecting the right coronary artery, conﬁrmed by invasive
coronary angiography, which revealed a tight stenosis in the right coronary artery (F, arrow). Abbreviations as in Figures 1 and 2.
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495(exercise ECG, SPECT, and stress echocardiogra-
phy) are all affected adversely by LBBB (7–9).
Cardiac CT angiography has been shown to have
good diagnostic accuracy in LBBB; however, in
patients with intermediate probability of CAD, such
as the population in our study, current guidelines
suggest the use of a functional test as ﬁrst-line
(10,11). Due to these limitations and the conse-
quent diagnostic uncertainty, many patients may
end up undergoing unnecessary ICA.
Unfortunately, the well-validated noninvasive
functional techniques for diagnosis of CAD are not
as diagnostically accurate in LBBB. Although the
sensitivity of SPECT remains high in patients with
LBBB, its speciﬁcity decreases, especially in the
septum (20). This is mainly due to false positives
caused by partial volume effects due to reduced
septal thickening. Stress echocardiography provides
better results and is presently recommended in pa-
tients with LBBB; however, results from published
studies are still variable. It has reduced sensitivity,
mainly due to false negatives caused by the abnormal
resting wall motion and myocardial thickening (9).
Geleijnse et al. (9) evaluated 64 patients with LBBB
using DSE and reported a sensitivity of 60% in theFigure 4. An Example of a Correct Diagnosis of LAD Disease by CM
A patient with an inducible septal wall motion abnormality (A and B, ar
(C and D, arrow). There is no signiﬁcant late gadolinium enhancement
left anterior descending (LAD) artery (F, arrow). CMR ¼ cardiac magneanterior circulation compared with 67% in the
posterior circulation. Other studies have been small
and reported mixed results (21,22). The reversible
wall motion abnormalities and perfusion defects
seen in the left anterior descending territory may
also be related to high heart rates during maximal
stress, and use of vasodilator stress does seem to
provide better results (20,23). These difﬁculties
mean that the ideal noninvasive imaging technique
has not yet been found for patients with LBBB. The
improved diagnostic accuracy of DSCMR in our
study is therefore encouraging.
DSCMR has been shown to have good diag-
nostic accuracy in patients with suspected CAD,
with several studies reporting good sensitivity and
speciﬁcity (24). In 1 of the largest studies using
DSCMR for detection of signiﬁcant CAD, using
CMR cine imaging alone, Gebker et al. (25) re-
ported sensitivity and speciﬁcity of 85% and 82%,
respectively, with an increase in sensitivity to 91%
with the addition of ﬁrst-pass perfusion, at the cost
of a decrease in speciﬁcity to 70% in 455 patients
(25). The investigators suggested that this was due
to the fact that perfusion defects tend to occur
before RWMA. The difﬁculty in assessing RWMAR Cine Imaging and First-Pass Perfusion
row). An inducible perfusion defect is seen at stress in the septal wall
(E). Intensive coronary angiography conﬁrmed a tight stenosis in the
tic resonance.
Figure 5. A Typical False Positive Seen by CMR Cine Imaging but Correctly Diagnosed in the Comprehensive Examination
This patient appears to have an inducible septal wall motion abnormality (A and B, arrow). There is no perfusion defect, however (C and D),
and no late gadolinium enhancement (E). Intensive coronary angiography revealed no signiﬁcant coronary artery disease (F). CMR ¼ cardiac
magnetic resonance.
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496in patients with LBBB would explain the lower
sensitivity seen in our study, which has reported a
similar speciﬁcity. The reduced sensitivity of CMR
cine imaging alone was also shown in a study by
Paetsch et al. (26), who reported a sensitivity of
78.2% and speciﬁcity of 87%.
Given the reduced sensitivity of DSCMR due to
the resting myocardial abnormalities in LBBB, we
also hypothesized that the addition of ﬁrst-pass
stress perfusion and LGE imaging would enhance
the diagnostic accuracy of the CMR examination,
which was proven to be correct. In a study by
Lubbers et al. (27), the investigators found that the
addition of ﬁrst-pass perfusion imaging during
dobutamine stress reduced the number of false
positives. Indeed, in their study, all 4 patients that
had an inducible wall motion abnormality with no
perfusion defect had LBBB. Our sensitivity and
speciﬁcity for DSE corresponds well to a study of 64
patients by Geleijnse et al. (9), also using dobut-
amine, which reported sensitivity of 68% and
speciﬁcity of 91%. As one might expect, the sensi-
tivity is similar using CMR cine imaging. The
similar number of false negatives may be due to the
observer attributing a true RWMA to the dyskinetic
motion of LBBB. The higher speciﬁcity of CMR
cine imaging (reduced false positives) may be due to
CMR’s increased spatial resolution, allowing for
greater diagnostic conﬁdence. In this respect, ourTable 4. Percentage of Patients Correctly Identiﬁed per Vessel by E
ICA DSE
No CAD 48 72.9 (35/48)
LAD 14 64.3 (9/14)
LCx 14 64.3 (9/14)
RCA 5 100.0 (5/5)
2-vessel disease 1 100.0 (1/1)
Values are n or % (n/N).
ICA ¼ invasive coronary angiography; LAD ¼ left anterior descending; LCX ¼ leftresults correspond fairly well to those of Nagel et al.
(28) in patients without LBBB, who also proposed
that the improved diagnostic accuracy using CMR
cine imaging alone was due to the increased spatial
resolution of CMR.
The addition of ﬁrst-pass stress perfusion and
LGE increased diagnostic accuracy markedly. Cine,
perfusion, and LGE imaging are 3 techniques that
can each independently diagnose CAD; hence, an
examination combining the 3 allows for greater
diagnostic conﬁdence. Of clinical importance is
the improved performance of the comprehensive
DSCMR examination in left-sided coronary dis-
ease, where the majority of problems lie with DSE.
Sensitivity increased from 64.2% with DSE to
82.1% with the comprehensive examination. One
could speculate that this may lead to some prog-
nostic beneﬁt in improved identiﬁcation of patients
who need invasive management. This has been
shown in a general population of patients with sus-
pected CAD (29). Similar to other studies, we have
shown that a comprehensive CMR examination can
be performed safely in routine clinical practice (29).
The additional value of LGE appears to be in
its increased speciﬁcity and/or positive predictive
value. It is important to remember that this may
only apply to a cohort with typical anginal symp-
toms and an intermediate or high probability of
CAD. An associated inducible perfusion defectchocardiography and CMR
CMR Cine Imaging Only Comprehensive DSCMR
87.5 (42/48) 95.8 (46/48)
57.1 (8/14) 71.4 (10/14)
78.6 (11/14) 92.9 (13/14)
80.0 (4/5) 80.0 (4/5)
100.0 (1/1) 100.0 (1/1)
circumﬂex; RCA ¼ right coronary artery; other abbreviations as in Tables 1 to 3.
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497along with the presence of LGE may indicate peri-
infarct ischemia. In other groups of patients, such
as those without anginal symptoms, this may not
apply as the presence of LGE may be more
indicative of a cardiomyopathy, especially if not in a
typical coronary distribution, obviating the need for
invasive angiography (30). We believe that the
increase in sensitivity found by using the compre-
hensive examination is probably due to the criteria
for a positive result, which means that a patient
must have either LGE (with or without a perfu-
sion defect) or an inducible RWMA and a perfu-
sion defect, meaning that the criteria are more
strict. This combination leads to the overall im-
proved diagnostic performance of the comprehen-
sive DSCMR examination.
We have also found that performing ﬁrst-pass
perfusion at an intermediate dose of dobutamine
appears to provide adequate diagnostic conﬁdence
for the assessment of inducible perfusion defects by
direct comparison against ICA. To the best of our
knowledge, there have been no studies that have
assessed the performance of ﬁrst-pass perfusion im-
aging at different dobutamine doses. However, pre-
vious studies suggest that the majority of the increase
in myocardial blood ﬂow and vasodilation caused
by dobutamine occurs at 20 mg/kg/min; beyond
this, there is simply an increase in heart rate and
contractility, which in our experience makes it more
difﬁcult to interpret perfusion (14–16). Furthermore,
the false positive perfusion defects seen in SPECT
are most often due to the fast heart rate at peak
stressdthe rate of false positives reduces signiﬁcantly
in patients with LBBBwhen vasodilator stress is used
rather than dobutamine (23).
Study limitations. Although our study is the ﬁrst
prospective evaluation of DSCMR in patients with
LBBB using CMR, there are some limitations. First,
although all patients in our study were referred for
ICA and this reduced post-test referral bias, we were
comparing a functional test (CMR) to an anatomical
test. The importance of the functional impact of
coronary stenoses has been well established, and wenow know that visual assessment of angiographic
stenoses is not optimal (31). Results may have been
different if we had compared CMR to a functional
invasive test such as fractional ﬂow reserve; however,
to combat this we only declared a signiﬁcant stenosis
to be over 70% by quantitative coronary angiography
analysis rather than 50%, which is most often used.
Our study was also conducted in a single center
with high volumes of CMR and angiography. It
may be difﬁcult to extrapolate this to lower-volume
centers. In addition, the number of patients in our-
study is relatively small. It is larger, however, than
many other diagnostic studies in this area. Further
information could be gained by larger, multicenter
trials with the potential for obtaining prognostic
information.
Last, we did not employ real-time 3-dimensional
echocardiography. Whether its addition might
improve both sensitivity and speciﬁcity of DSE
has not been evaluated prospectively in patients
with LBBB and suspected CAD. The addition of
strain analysis has also been shown to improve dia-
gnostic accuracy of DSE (32).CONCLUS IONS
Comprehensive DSCMR is a feasible, safe, non-
invasive investigation for the exclusion of CAD
in patients with LBBB that outperforms DSE.
The addition of perfusion and LGE sequences
to CMR cine imaging improves sensitivity, speci-
ﬁcity, and overall diagnostic accuracy. Compre-
hensive DSCMR provides a viable noninvasive
functional investigation for LBBB and suspected
CAD and may overcome some of the disadvantages
of DSE in this group.
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